Báo cáo khoa học: "Correction: Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings" pdf

560
Critical Care December 2005 Vol 9 No 6 Grounds and Bolan
Following the publication of the above article [1], we noticed
that the Competing interests section was incorrect and
should read as follows:
RMG has worked as a consultant for Novo Nordisk and
lectured on behalf of Novo Nordisk about NovoSeven.
References
1. Grounds RM, Bolan C: Clinical experiences and current evi-
dence for therapeutic recombinant factor VIIa treatment in
nontrauma settings. Crit Care 2005, 9(Suppl 5):S29-S36.
Correction
Correction: Clinical experiences and current evidence for
therapeutic recombinant factor VIIa treatment in nontrauma
settings
R Michael Grounds
1
and Charles Bolan
2
1
Adult Intensive Care Unit, St George's Hospital, London, UK
2
COL (retired) US Army Medical Corps, Deputy Chief, Blood Services Section, Department of Transfusion Medicine, Clinical Centre, National
Institutes of Health, Bethesda, Maryland, USA
Corresponding author: R Michael Grounds,
Published online: 4 November 2005 Critical Care 2005, 9:560 (DOI 10.1186/cc3926)
This article is online at />© 2005 BioMed Central Ltd